Seeking Alpha

EBIO
Eleven Biotherapeutics, Inc. - NASDAQ

4/25/2014, 5:59 AM ET
Quote & Analysis Breaking News StockTalk
ebio chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
There are no Transcripts on EBIO.
EBIO vs. ETF Alternatives
Company Description

Eleven Biotherapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.

Sector: Healthcare
Industry: Biotechnology
Country: United States
OTHER NEWS